Literature DB >> 10412048

Involvement of p38 mitogen-activated protein kinase in basic fibroblast growth factor-induced interleukin-6 synthesis in osteoblasts.

O Kozawa1, H Tokuda, H Matsuno, T Uematsu.   

Abstract

We previously showed that basic fibroblast growth factor (bFGF)-induced activation of protein kinase C (PKC) via phosphatidylinositol-hydrolyzing phospholipase C and phosphatidylcholine-hydrolyzing phospholipase D suppresses interleukin-6 (IL-6) synthesis by bFGF itself in osteoblast-like MC3T3-E1 cells. In the present study, we further investigated the mechanism underlying the bFGF-induced IL-6 synthesis in MC3T3-E1 cells. bFGF time-dependently induced the phosphorylation of p38 mitogen-activated protein (MAP) kinase. SB203580, a specific inhibitor of p38 MAP kinase, suppressed the bFGF-induced IL-6 synthesis dose-dependently. The phosphorylation of p38 MAP kinase by bFGF was suppressed by TMB-8, an inhibitor of intracellular Ca(2+) mobilization, or the depletion of extracellular Ca(2+) with EGTA. A23187, a Ca-ionophore, stimulated the phosphorylation of p38 MAP kinase. SB203580 inhibited the A23187-induced synthesis of IL-6. 1-Oleoyl-2-acetyl-sn-glycerol, a synthetic diacylglycerol activating PKC, reduced the bFGF-induced IL-6 synthesis. 12-O-Tetradecanoylphorbol-13-acetate, an activator of PKC, attenuated the phosphorylation of p38 MAP kinase by bFGF, but did not affect the A23187-induced phosphorylation. These results strongly suggest that bFGF-induced IL-6 synthesis is mediated via p38 MAP kinase activation in osteoblasts, and that PKC acts at a point upstream from p38 MAP kinase. Copyright 1999 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10412048

Source DB:  PubMed          Journal:  J Cell Biochem        ISSN: 0730-2312            Impact factor:   4.429


  8 in total

Review 1.  Signaling and transcriptional regulation in osteoblast commitment and differentiation.

Authors:  Wei Huang; Shuying Yang; Jianzhong Shao; Yi-Ping Li
Journal:  Front Biosci       Date:  2007-05-01

Review 2.  Signaling networks that control the lineage commitment and differentiation of bone cells.

Authors:  Carrie S Soltanoff; Shuying Yang; Wei Chen; Yi-Ping Li
Journal:  Crit Rev Eukaryot Gene Expr       Date:  2009       Impact factor: 1.807

3.  RhoC GTPase overexpression modulates induction of angiogenic factors in breast cells.

Authors:  K L van Golen; Z F Wu; X T Qiao; L Bao; S D Merajver
Journal:  Neoplasia       Date:  2000 Sep-Oct       Impact factor: 5.715

4.  Receptor isoforms mediate opposing proliferative effects through gbetagamma-activated p38 or Akt pathways.

Authors:  L A Sellers; F Alderton; A M Carruthers; M Schindler; P P Humphrey
Journal:  Mol Cell Biol       Date:  2000-08       Impact factor: 4.272

5.  p38 MAP kinase signalling is required for hypertrophic chondrocyte differentiation.

Authors:  Lee-Anne Stanton; Shalev Sabari; Arthur V Sampaio; T Michael Underhill; Frank Beier
Journal:  Biochem J       Date:  2004-02-15       Impact factor: 3.857

6.  Down-regulation by resveratrol of basic fibroblast growth factor-stimulated osteoprotegerin synthesis through suppression of Akt in osteoblasts.

Authors:  Gen Kuroyanagi; Takanobu Otsuka; Naohiro Yamamoto; Rie Matsushima-Nishiwaki; Akira Nakakami; Jun Mizutani; Osamu Kozawa; Haruhiko Tokuda
Journal:  Int J Mol Sci       Date:  2014-10-06       Impact factor: 5.923

Review 7.  p38 MAPK Signaling in Osteoblast Differentiation.

Authors:  Eddie Rodríguez-Carballo; Beatriz Gámez; Francesc Ventura
Journal:  Front Cell Dev Biol       Date:  2016-05-06

8.  EMMPRIN Inhibits bFGF-Induced IL-6 Secretion in an Osteoblastic Cell Line, MC3T3-E1.

Authors:  Akari Saiki; Mitsuru Motoyoshi; Keiko Motozawa; Teinosuke Okamura; Kousuke Ueki; Noriyoshi Shimizu; Masatake Asano
Journal:  Int J Med Sci       Date:  2017-09-19       Impact factor: 3.738

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.